English
简体中文
繁體中文
客服热线:400-1616-289
登录
注册
会议论文
Camrelizumab combined with lenvatinib and RALOX-HAIC for hepatocellular carcinoma (HCC) in BCLC stage B and C: A prospective, single-arm, phase II trial (Cal Era study)
Zang, M.; Li, Q.; Pang, H.; Hu, X.; Li, R.; Yuan, G.; Li, W.; Guo, Y.; Chen, J.
南方医科大学
Annual Meeting of the European-Society-for-Medical-Oncology (ESMO)
2022-9
DOI: 10.1016/j.annonc.2022.07.850
15
阅读
引用
收藏
分享
相关
加载中…
文献加载失败,请重试
重试